A detailed history of Sageworth Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Sageworth Trust CO holds 35,995 shares of ABT stock, worth $4.64 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
35,995
Previous 51,848 30.58%
Holding current value
$4.64 Million
Previous $5.91 Million 31.13%
% of portfolio
0.25%
Previous 0.36%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

SELL
$111.93 - $119.39 $1.77 Million - $1.89 Million
-15,853 Reduced 30.58%
35,995 $4.07 Million
Q3 2024

Oct 24, 2024

SELL
$100.07 - $118.13 $1.14 Million - $1.35 Million
-11,417 Reduced 18.05%
51,848 $5.91 Million
Q2 2024

Jul 16, 2024

SELL
$100.73 - $112.44 $242,860 - $271,092
-2,411 Reduced 3.67%
63,265 $6.57 Million
Q1 2024

Apr 16, 2024

SELL
$109.52 - $120.96 $65,712 - $72,576
-600 Reduced 0.91%
65,676 $7.46 Million
Q3 2023

Oct 11, 2023

BUY
$95.53 - $114.62 $3.03 Million - $3.63 Million
31,706 Added 91.72%
66,276 $6.42 Million
Q3 2022

Nov 02, 2022

SELL
$96.76 - $112.03 $194,003 - $224,620
-2,005 Reduced 5.48%
34,570 $3.35 Million
Q2 2022

Jul 28, 2022

BUY
$102.07 - $123.37 $204,650 - $247,356
2,005 Added 5.8%
36,575 $3.97 Million
Q1 2022

May 06, 2022

SELL
$114.02 - $139.04 $274,902 - $335,225
-2,411 Reduced 6.52%
34,570 $4.09 Million
Q3 2021

Nov 09, 2021

SELL
$116.66 - $129.06 $34,998 - $38,718
-300 Reduced 0.8%
36,981 $4.37 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $26,230 - $30,903
-241 Reduced 0.64%
37,281 $4.47 Million
Q4 2020

Feb 08, 2021

BUY
$105.0 - $114.42 $25,305 - $27,575
241 Added 0.65%
37,522 $4.11 Million
Q3 2020

Nov 04, 2020

SELL
$91.64 - $111.29 $6.14 Million - $7.46 Million
-67,026 Reduced 64.26%
37,281 $4.06 Million
Q2 2020

Aug 12, 2020

BUY
$76.57 - $98.0 $1,990 - $2,548
26 Added 0.02%
104,307 $9.54 Million
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $374,784 - $548,036
-5,966 Reduced 5.41%
104,281 $8.23 Million
Q4 2019

Jan 28, 2020

SELL
$78.51 - $87.4 $148,619 - $165,448
-1,893 Reduced 1.69%
110,247 $9.58 Million
Q3 2019

Oct 31, 2019

SELL
$81.84 - $88.74 $61,543 - $66,732
-752 Reduced 0.67%
112,140 $9.38 Million
Q2 2019

Jul 19, 2019

BUY
$72.88 - $85.0 $214,631 - $250,325
2,945 Added 2.68%
112,892 $9.49 Million
Q3 2018

Oct 30, 2018

BUY
$60.81 - $73.36 $31,986 - $38,587
526 Added 0.48%
109,947 $8.07 Million
Q1 2018

May 03, 2018

SELL
$56.27 - $63.62 $112,877 - $127,621
-2,006 Reduced 1.8%
109,421 $6.56 Million
Q4 2017

Jan 31, 2018

SELL
$53.68 - $57.47 $28,235 - $30,229
-526 Reduced 0.47%
111,427 $6.36 Million
Q3 2017

Oct 23, 2017

BUY
$48.06 - $53.64 $5.38 Million - $6.01 Million
111,953
111,953 $5.97 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sageworth Trust CO Portfolio

Follow Sageworth Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sageworth Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sageworth Trust CO with notifications on news.